Myeloma and Related Diseases Registry (MRDR)

Helping clinicians and hospitals to provide the best possible care to people with multiple myeloma and related diseases.

View our 2025 Annual Report here

This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.

What is the registry?

Learn about how the registry works and the data we collect.
Benefits

Participation in the registry provides advantages for sites and patients.
About our projects

Find out about MRDR projects and how registry data is being used.
9551

Patients accrued

6830

Patients with multiple myeloma

66

Number of approved sites

833

M1000 Biobank participants

Latest news

Program Available: 2026 MRDR Annual Breakfast Meeting
21 Sep 2026

Monday 19 October, 7.00am NZDT, Weta Uncorked, Auckland, New Zealand

Read more
Highlighting a New MRDR Publication!
16 Sep 2026

New research using MRDR data explores toxicity-related treatment cessation and survival outcomes in newly diagnosed multiple myeloma patients.

Read more
Celebrating nurses this Cancer Nurses Day!
13 Aug 2026

We are proud to celebrate you today!

Read more
Save the date: 2026 MRDR Annual Breakfast Meeting
24 May 2026

Monday 19 October, 7.00am NZDT, Weta Uncorked, Auckland, New Zealand

Read more

Participating organisations